Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3729)
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
428
Price
$257.63
Total Value
$110.27K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
149
Price
$258.81
Total Value
$38.56K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
200
Price
$258.28
Total Value
$51.66K
Shares Held After
149
% of Holdings
57.3%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
859
Price
$257.59
Total Value
$221.27K
Shares Held After
349
% of Holdings
71.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
741
Price
$256.23
Total Value
$189.87K
Shares Held After
1,208
% of Holdings
38.0%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
626
Price
$261.20
Total Value
$163.51K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
120
Price
$257.53
Total Value
$30.90K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
49
Price
$256.39
Total Value
$12.56K
Shares Held After
120
% of Holdings
29.0%
BeOne Medicines Ltd. (ONC)
Rosenberg Aaron — Chief Financial Officer
Shares
631
Price
$257.74
Total Value
$162.64K
Shares Held After
0
% of Holdings
100.0%
Corvus Pharmaceuticals, Inc. (CRVS)
Moore David Scott — Director
Shares
21,700
Price
$11.53
Total Value
$250.24K
Shares Held After
21,700
% of Holdings
100.0%
Pelthos Therapeutics Inc. (PTHS)
Davis Todd C — Director
Shares
503
Price
$28.73
Total Value
$14.45K
Shares Held After
75,834
% of Holdings
0.7%
Pelthos Therapeutics Inc. (PTHS)
Davis Todd C — Director
Shares
35,445
Price
$27.80
Total Value
$985.53K
Shares Held After
75,331
% of Holdings
47.1%
Keros Therapeutics, Inc. (KROS)
Newton Charles W. — Director
Shares
550
Price
$10.04
Total Value
$5.52K
Shares Held After
12,665
% of Holdings
4.2%
CervoMed Inc. (CRVO)
BOGER JOSHUA S — Director
Shares
955,414
Price
$3.14
Total Value
$3.00M
Shares Held After
1,795,865
% of Holdings
53.2%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
19,131
Price
$70.28
Total Value
$1.34M
Shares Held After
121,863
% of Holdings
13.6%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
5,749
Price
$70.28
Total Value
$404.03K
Shares Held After
140,994
% of Holdings
3.9%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
200
Price
$150.17
Total Value
$30.03K
Shares Held After
158,222
% of Holdings
0.1%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
4,600
Price
$149.64
Total Value
$688.36K
Shares Held After
158,422
% of Holdings
2.8%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
1,800
Price
$148.72
Total Value
$267.70K
Shares Held After
163,022
% of Holdings
1.1%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
500
Price
$147.27
Total Value
$73.64K
Shares Held After
164,822
% of Holdings
0.3%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
700
Price
$146.04
Total Value
$102.23K
Shares Held After
165,322
% of Holdings
0.4%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
885
Price
$145.15
Total Value
$128.46K
Shares Held After
166,022
% of Holdings
0.5%
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
1,315
Price
$144.28
Total Value
$189.73K
Shares Held After
166,907
% of Holdings
0.8%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
2,800
Price
$6.17
Total Value
$17.28K
Shares Held After
700,000
% of Holdings
0.4%
Serina Therapeutics, Inc. (SER)
WILSON KAREN J — Director
Shares
5,100
Price
$1.75
Total Value
$8.90K
Shares Held After
5,100
% of Holdings
100.0%
uniQure N.V. (QURE)
Meek David D. — Director
Shares
1,993
Price
$27.06
Total Value
$53.93K
Shares Held After
39,747
% of Holdings
4.8%
uniQure N.V. (QURE)
O'Keefe Kylie — Chief Customer & Strat Officer
Shares
15,936
Price
$27.06
Total Value
$431.23K
Shares Held After
108,864
% of Holdings
12.8%
uniQure N.V. (QURE)
Gut Robert — Director
Shares
2,726
Price
$27.06
Total Value
$73.77K
Shares Held After
32,259
% of Holdings
7.8%
uniQure N.V. (QURE)
Springhorn Jeremy P. — Director
Shares
1,993
Price
$27.06
Total Value
$53.93K
Shares Held After
43,251
% of Holdings
4.4%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
22,417
Price
$70.13
Total Value
$1.57M
Shares Held After
51,326
% of Holdings
30.4%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
125,000
Price
$8.17
Total Value
$1.02M
Shares Held After
1,061,000
% of Holdings
11.8%
uniQure N.V. (QURE)
POST LEONARD E — Director
Shares
1,993
Price
$27.06
Total Value
$53.93K
Shares Held After
35,494
% of Holdings
5.3%
LIGAND PHARMACEUTICALS INC (LGND)
Aryeh Jason — Director
Shares
4,500
Price
$250.00
Total Value
$1.12M
Shares Held After
102,580
% of Holdings
4.2%
uniQure N.V. (QURE)
Balachandran Madhavan — Director
Shares
1,993
Price
$27.06
Total Value
$53.93K
Shares Held After
43,254
% of Holdings
4.4%
uniQure N.V. (QURE)
Jacques Rachelle Suzanne — Director
Shares
1,993
Price
$27.06
Total Value
$53.93K
Shares Held After
33,903
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
320
Price
$551.83
Total Value
$176.58K
Shares Held After
18,876
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,560
Price
$551.10
Total Value
$859.71K
Shares Held After
19,196
% of Holdings
7.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,333
Price
$550.04
Total Value
$1.83M
Shares Held After
20,756
% of Holdings
13.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,974
Price
$549.11
Total Value
$1.08M
Shares Held After
24,089
% of Holdings
7.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,037
Price
$548.02
Total Value
$1.12M
Shares Held After
26,063
% of Holdings
7.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
134
Price
$547.08
Total Value
$73.31K
Shares Held After
28,100
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
442
Price
$545.14
Total Value
$240.95K
Shares Held After
28,234
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
154
Price
$544.37
Total Value
$83.83K
Shares Held After
28,676
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
46
Price
$542.94
Total Value
$24.98K
Shares Held After
28,830
% of Holdings
0.2%
Syndax Pharmaceuticals Inc (SNDX)
Botwood Nicholas A.J. — Head of R&D, CMO
Shares
34,280
Price
$18.00
Total Value
$617.04K
Shares Held After
60,885
% of Holdings
36.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$551.87
Total Value
$176.60K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,400
Price
$551.15
Total Value
$771.60K
Shares Held After
40,833
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,939
Price
$550.07
Total Value
$1.62M
Shares Held After
42,233
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,936
Price
$549.21
Total Value
$1.06M
Shares Held After
45,172
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,006
Price
$548.09
Total Value
$1.10M
Shares Held After
47,108
% of Holdings
4.1%
Showing 951–1000 of 3729 transactions (page 20 of 75)